Clinical-stage biopharmaceutical group Pharnext has appointed Amit Kohli as its new chief operating officer, a role which will see him take responsibility for leading Pharnext’s corporate strategy and operations.
Before joining Pharnext, Kohli was general manager of clinical diagnostics at Eurofins based in Brussels, where he led business expansion across Europe and the Middle East.
He has also held a number of leadership roles with Sanofi in sales, marketing, finance, supply chain and manufacturing.
Daniel Cohen, co-founder and chief executive officer of Pharnext, said: “Amit is a seasoned leader with over 20 years’ experience in the healthcare industry, and we are thrilled he is joining Pharnext.”
No results were found
For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...